169 related articles for article (PubMed ID: 3280194)
1. Oncogene expression in related cancer lines differing in metastatic capacity.
Pohl J; Radler-Pohl A; Heicappell R; Schirrmacher V
Clin Exp Metastasis; 1988; 6(3):201-11. PubMed ID: 3280194
[TBL] [Abstract][Full Text] [Related]
2. Persistence of Ha-ras-induced metastatic potential of SP1 mouse mammary tumors despite loss of the Ha-ras shuttle vector.
Schlatter B; Waghorne CG
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):9986-90. PubMed ID: 1438249
[TBL] [Abstract][Full Text] [Related]
3. Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with the v-H-ras oncogene.
Kyprianou N; Isaacs JT
Cancer Res; 1990 Mar; 50(5):1449-54. PubMed ID: 2105838
[TBL] [Abstract][Full Text] [Related]
4. Enhanced spontaneous metastasis of mouse carcinoma cells transfected with an activated c-Ha-ras-1 gene.
Vousden KH; Eccles SA; Purvies H; Marshall CJ
Int J Cancer; 1986 Mar; 37(3):425-33. PubMed ID: 3949424
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous progression of hyperplastic outgrowths of the D1 lineage to mammary tumors: expression of mouse mammary tumor virus and cellular proto-oncogenes.
Knepper JE; Kittrell FS; Medina D; Butel JS
Mol Carcinog; 1989; 1(4):229-38. PubMed ID: 2551332
[TBL] [Abstract][Full Text] [Related]
6. Metastatic ability and expression of c-fos oncogene in cell clones of a spontaneous rat mammary tumor.
Yuhki N; Hamada J; Kuzumaki N; Takeichi N; Kobayashi H
Jpn J Cancer Res; 1986 Jan; 77(1):9-12. PubMed ID: 3082820
[TBL] [Abstract][Full Text] [Related]
7. Suggestive evidence that the highly metastatic variant ESb of the T-cell lymphoma Eb is derived from spontaneous fusion with a host macrophage.
Larizza L; Schirrmacher V; Graf L; Pflüger E; Peres-Martinez M; Stöhr M
Int J Cancer; 1984 Nov; 34(5):699-707. PubMed ID: 6500746
[TBL] [Abstract][Full Text] [Related]
8. Clonal heterogeneity, experimental metastatic ability, and p21 expression in H-ras-transformed NIH 3T3 cells.
Hill SA; Wilson S; Chambers AF
J Natl Cancer Inst; 1988 Jun; 80(7):484-90. PubMed ID: 3285012
[TBL] [Abstract][Full Text] [Related]
9. Association of hst gene expression with metastatic phenotype in mouse mammary tumors.
Murakami A; Tanaka H; Matsuzawa A
Cell Growth Differ; 1990 May; 1(5):225-31. PubMed ID: 1964796
[TBL] [Abstract][Full Text] [Related]
10. Alterations in the Ha-ras-1 and the p53 pathway genes in the progression of N-methyl-N-nitrosourea-induced rat mammary tumors.
McKenzie KE; Armstrong BA; Chen Y; Nagarajan M; Aldaz CM; Sukumar S
Mol Carcinog; 1997 Oct; 20(2):194-203. PubMed ID: 9364209
[TBL] [Abstract][Full Text] [Related]
11. Genetic factors and suppression of metastatic ability of v-Ha-ras-transfected rat mammary cancer cells.
Ichikawa T; Ichikawa Y; Isaacs JT
Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1607-10. PubMed ID: 1542651
[TBL] [Abstract][Full Text] [Related]
12. Suppression of tumorigenicity in human cell hybrids derived from cell lines expressing different activated ras oncogenes.
Geiser AG; Anderson MJ; Stanbridge EJ
Cancer Res; 1989 Mar; 49(6):1572-7. PubMed ID: 2647289
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
Hal DG; Stoica G
Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
[TBL] [Abstract][Full Text] [Related]
14. Suppression of the metastatic phenotype of a mouse skin carcinoma cell line independent of E-cadherin expression and correlated with reduced Ha-ras oncogene products.
Caulín C; López-Barcons L; Gonzáles-Garrigues M; Navarro P; Lozano E; Rodrigo I; Gamallo C; Cano A; Fabra A; Quintanilla M
Mol Carcinog; 1996 Feb; 15(2):104-14. PubMed ID: 8599577
[TBL] [Abstract][Full Text] [Related]
15. Harvey-ras mediated neoplastic development in the mouse mammary gland.
Strange R; Aguilar-Cordova E; Young LJ; Billy HT; Dandekar S; Cardiff RD
Oncogene; 1989 Mar; 4(3):309-15. PubMed ID: 2784851
[TBL] [Abstract][Full Text] [Related]
16. Selection for spontaneous metastasis after calcium phosphate-mediated transfer of DNA.
Muschel RJ
Cancer Res; 1990 Sep; 50(17):5581-6. PubMed ID: 2201438
[TBL] [Abstract][Full Text] [Related]
17. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
[TBL] [Abstract][Full Text] [Related]
18. Correlation between Ha-ras gene amplification and spontaneous metastasis in NIH 3T3 cells transfected with genomic DNA from human skin cancers.
Ananthaswamy HN; Price JE; Tainsky MA; Goldberg LH; Bales ES
Clin Exp Metastasis; 1989; 7(3):301-13. PubMed ID: 2647332
[TBL] [Abstract][Full Text] [Related]
19. Metastatic potential of SP1 mouse mammary adenocarcinoma cells is differentially induced by activated and normal forms of c-H-ras.
Waghorne C; Kerbel RS; Breitman ML
Oncogene; 1987 May; 1(2):149-55. PubMed ID: 3325879
[TBL] [Abstract][Full Text] [Related]
20. Glycoconjugates of murine tumor lines with different metastatic capacities. I. Differences in fucose utilization and in glycoprotein patterns.
Schwartz R; Schirrmacher V; Mühlradt PF
Int J Cancer; 1984 Apr; 33(4):503-9. PubMed ID: 6706434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]